Published in Am Heart J on January 01, 2005
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) | NCT00000556
Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses. J Am Coll Cardiol (2011) 2.42
Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation (2011) 2.36
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate. Circulation (2015) 2.12
Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation (2012) 1.67
Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides. Neth Heart J (2016) 1.38
A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale. Can J Cardiol (2006) 1.15
Rate control in the medical management of atrial fibrillation. Heart (2006) 1.13
Quality of life in atrial fibrillation: measurement tools and impact of interventions. J Cardiovasc Electrophysiol (2008) 1.05
Validity and reliability of a new, short symptom rating scale in patients with persistent atrial fibrillation. Health Qual Life Outcomes (2009) 1.05
2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg (2014) 0.99
Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation. Heart (2006) 0.93
Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc (2009) 0.93
Effects of expanded cardiac rehabilitation on psychosocial status in coronary artery disease with focus on type D characteristics. J Behav Med (2007) 0.92
Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J (2013) 0.86
Health-related quality of life changes in patients undergoing repeated catheter ablation for atrial fibrillation. Clin Res Cardiol (2015) 0.85
NORMAL QUALITY OF LIFE AFTER THE COX MAZE PROCEDURE FOR ATRIAL FIBRILLATION. Innovations (Phila) (2008) 0.84
Long-term outcomes (>2 years) of atrial fibrillation ablation using a multi-electrode ablation catheter in patients with paroxysmal atrial fibrillation. J Interv Card Electrophysiol (2012) 0.83
Development and validation of a new Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) with focus on symptom burden. Health Qual Life Outcomes (2012) 0.82
Conventional pulmonary vein isolation compared with the "box isolation" method: a randomized clinical trial. J Interv Card Electrophysiol (2011) 0.80
Symptomatic improvement after catheter ablation of supraventricular tachycardia measured by the arrhythmia-specific questionnaire U22. Ups J Med Sci (2010) 0.80
Atrial Fibrillation and Race - A Contemporary Review. Curr Cardiovasc Risk Rep (2013) 0.80
The transition to value-based care. J Interv Card Electrophysiol (2016) 0.78
Pharmacotherapy for rhythm management in elderly patients with atrial fibrillation. J Interv Card Electrophysiol (2009) 0.78
Health-related quality of life questionnaires: an important method to evaluate patient outcomes in atrial fibrillation ablation. J Interv Card Electrophysiol (2012) 0.78
Exercise in patients receiving hematopoietic stem cell transplantation: lessons learned and results from a feasibility study. Oncol Nurs Forum (2011) 0.78
Atrial electromechanical cycle length mapping in paced canine hearts in vivo. IEEE Trans Ultrason Ferroelectr Freq Control (2015) 0.77
Responsiveness of AF6, a new, short, validated, atrial fibrillation-specific questionnaire--symptomatic benefit of direct current cardioversion. J Interv Card Electrophysiol (2010) 0.77
Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol (2015) 0.76
U22 protocol as measure of symptomatic improvement after catheter ablation of atrial fibrillation. Ups J Med Sci (2013) 0.76
Comparison of circumferential pulmonary vein isolation and antiarrhythmic drug therapy in patients with atrial fibrillation. Cardiol Ther (2012) 0.75
Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing. BMC Cardiovasc Disord (2016) 0.75
Atrial fibrillation (chronic). BMJ Clin Evid (2011) 0.75
Atrial fibrillation (chronic). BMJ Clin Evid (2008) 0.75
Atrial fibrillation and quality of life: clarity or evidence-based confusion? Am Heart J (2005) 0.75
Symptoms In Atrial Fibrillation: A Contemporary Review And Future Directions. J Atr Fibrillation (2016) 0.75
Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study. Patient Prefer Adherence (2013) 0.75
Assessing quality-of-life outcomes in cardiovascular clinical research. Nat Rev Cardiol (2016) 0.75
Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials. Clin Med Insights Cardiol (2013) 0.75
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. J Am Coll Cardiol (2004) 5.05
Targeted mutagenesis by homologous recombination in D. melanogaster. Genes Dev (2002) 4.21
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation (2004) 4.04
Azithromycin for the secondary prevention of coronary events. N Engl J Med (2005) 3.42
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med (2002) 3.35
Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med (2002) 3.17
Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol (2013) 2.43
High-resolution retinal imaging of cone-rod dystrophy. Ophthalmology (2006) 2.13
Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation (2004) 1.99
Adaptive optics retinal imaging reveals S-cone dystrophy in tritan color-vision deficiency. J Opt Soc Am A Opt Image Sci Vis (2007) 1.91
Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm (2005) 1.83
Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy. J Am Coll Cardiol (2005) 1.77
Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend (2009) 1.77
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience. Heart Rhythm (2004) 1.70
Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol (2003) 1.59
Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med (2004) 1.52
Predictors of stroke in patients paced for sick sinus syndrome. J Am Coll Cardiol (2004) 1.52
Activation of a meiotic checkpoint during Drosophila oogenesis regulates the translation of Gurken through Chk2/Mnk. Curr Biol (2002) 1.51
The idiopathic intracranial hypertension treatment trial: design considerations and methods. J Neuroophthalmol (2014) 1.40
Lack of benefit for routine functional testing early after coronary artery bypass graft surgery: results from the ROSETTA-CABG Registry. J Invasive Cardiol (2006) 1.40
Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J (2005) 1.40
Conducting research using the emergency exception from informed consent: the Public Access Defibrillation (PAD) Trial experience. Resuscitation (2004) 1.39
Short chain fatty acids and their receptors: new metabolic targets. Transl Res (2012) 1.31
Task force #4--adherence issues and behavior changes: achieving a long-term solution. 33rd Bethesda Conference. J Am Coll Cardiol (2002) 1.16
Coats syndrome in facioscapulohumeral dystrophy type 1: frequency and D4Z4 contraction size. Neurology (2013) 1.14
Matching approved "nondedicated" hardware to obtain biventricular pacing and defibrillation: feasibility and troubleshooting. Pacing Clin Electrophysiol (2002) 1.12
Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol (2005) 1.11
Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation (2012) 1.03
Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye. Surv Ophthalmol (2009) 1.01
Association of a novel mutation in the retinol dehydrogenase 12 (RDH12) gene with autosomal dominant retinitis pigmentosa. Arch Ophthalmol (2008) 0.99
The anti-inflammatory mechanism of 635 nm light-emitting-diode irradiation compared with existing COX inhibitors. Lasers Surg Med (2007) 0.97
Postoperative performance of the Quartet® left ventricular heart lead. J Cardiovasc Electrophysiol (2013) 0.97
Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm (2004) 0.93
Dissimilar ventricular rhythms: implications for ICD therapy. Heart Rhythm (2012) 0.93
A 9 year-old girl with herpes simplex virus type 2 acute retinal necrosis treated with intravitreal foscarnet. Ocul Immunol Inflamm (2007) 0.90
Safety and efficacy of radiofrequency energy catheter ablation of atrial fibrillation in patients with pacemakers and implantable cardiac defibrillators. Heart Rhythm (2005) 0.90
The end-of-study patient survey: methods influencing response rate in the AVID Trial. Control Clin Trials (2002) 0.89
Use of amiodarone for atrial fibrillation in patients with preexisting pulmonary disease in the AFFIRM study. Am J Cardiol (2005) 0.88
Multi-modal imaging: simultaneous MRI and ultrasound imaging for carotid arteries visualization. Conf Proc IEEE Eng Med Biol Soc (2007) 0.87
Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation. Circulation (2011) 0.87
ACP Journal Club. Review: NSAIDs increase GI and CV events; coxibs increase mortality. Ann Intern Med (2013) 0.86
Adaptive optics for retinal imaging: current status. Retina (2013) 0.86
Personalizing death in the intensive care unit: the 3 Wishes Project: a mixed-methods study. Ann Intern Med (2015) 0.86
Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J (2005) 0.85
Retinal crystals in type 2 idiopathic macular telangiectasia. Ophthalmology (2011) 0.85
Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). Heart Rhythm (2006) 0.84
Heart failure in older adults: keys to successful management. AACN Clin Issues (2002) 0.83
Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis. J Am Coll Cardiol (2004) 0.81
Assessing the impact of censoring of costs and effects on health-care decision-making: an example using the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Value Health (2007) 0.81
Myocardial compliance was not altered after acute induction of atrial fibrillation in sheep. Med Sci Monit (2005) 0.81
Who goes to treatment? Predictors of treatment initiation among gambling help-line callers. Am J Addict (2013) 0.80
Frequency of symptomatic atrial fibrillation in patients enrolled in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. J Cardiovasc Electrophysiol (2002) 0.80
Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am J Cardiol (2003) 0.80
Bone graft substitutes for anterior lumbar interbody fusion. Orthop Surg (2013) 0.79
Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction. Circulation (2005) 0.78
Response to Letter by May et al regarding article, "Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation" by Bassiouny et al. Circ Arrhythm Electrophysiol (2013) 0.78
Group B streptococcal endogenous endophthalmitis in a neonate. Retina (2006) 0.78
Quantitative analysis of Hedgehog gradient formation using an inducible expression system. BMC Dev Biol (2007) 0.78
Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect. J Child Neurol (2004) 0.78
HFSA and AAHFN joint position statement: advocating for a full scope of nursing practice and leadership in heart failure. J Card Fail (2012) 0.78
The association of the heart failure score with mortality and heart failure hospitalizations in elderly patients: insights from the Mode Selection Trial (MOST). Am Heart J (2006) 0.77
Intraoperative electro-anatomical mapping and beating heart ablation of ventricular tachycardia. Ann Thorac Surg (2006) 0.77
Measuring survival rates from sudden cardiac arrest: the elusive definition. Resuscitation (2004) 0.77
Is health-related quality of life a predictor of hospitalization or mortality among women or men with atrial fibrillation? J Cardiovasc Nurs (2014) 0.77
Impact of invasive management versus noninvasive management on functional status and quality of life following non-Q-wave myocardial infarction: a randomized clinical trial. Am Heart J (2005) 0.77
Death in patients with permanent pacemakers for sick sinus syndrome. Am Heart J (2003) 0.77
Impact of diabetes on 12-month outcomes following coronary artery bypass graft surgery: results from the ROSETTA-CABG Registry. Can J Cardiol (2005) 0.76
ACP Journal Club. Glargine did not reduce CV events more than standard care in patients with dysglycemia. Ann Intern Med (2012) 0.75
Where do diagnostic adverse events come from? Arch Intern Med (2011) 0.75
ACP Journal Club. Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia. Ann Intern Med (2012) 0.75
ACP Journal Club. In noncardiac surgery, perioperative aspirin did not reduce death or MI at 30 d but increased major bleeding. Ann Intern Med (2014) 0.75
Marlow occlusion: does it create or eliminate artifact? Strabismus (2005) 0.75
Marlow occlusion: does it create or eliminate artifact? Strabismus (2005) 0.75
Usefulness of clinical information to distinguish patients with normal from those with low ejection fractions in heart failure. Am J Cardiol (2002) 0.75
Ancillary studies in clinical trials. Nurs Res (2002) 0.75
Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy. Pharmacogenet Genomics (2017) 0.75
A comparison of the AVID and DAVID trials of implantable defibrillators. Am J Cardiol (2005) 0.75
Impact of functional testing results on prescription patterns of anti-anginal medication after coronary artery bypass graft surgery: results from the ROSETTA-CABG Registry. J Invasive Cardiol (2006) 0.75
Use of stress testing early after coronary artery bypass graft surgery. Am J Cardiol (2006) 0.75
Familial cold-induced transient diplopia. Strabismus (2008) 0.75
Neurohormone activation. Crit Care Nurs Clin North Am (2003) 0.75
HFSA and AAHFN joint position statement: advocating for a full scope of nursing practice and leadership in heart failure. Heart Lung (2012) 0.75
Public defibrillation: increased survival from a structured response system. J Cardiovasc Nurs (2004) 0.75
Heart transplant for anomalous origin of left coronary artery from pulmonary artery. Ann Thorac Surg (2003) 0.75